Corebridge Financial’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,787	Closed	-$11.7K	–	41
2025 Q1	$11.7K	Sell	5,787 -86	-1%	-$175	﹤0.01%	2959
2024 Q4	$35.4K	Sell	5,873 -443	-7%	-$2.67K	﹤0.01%	2900
2024 Q3	$44.2K	Sell	6,316 -39	-0.6%	-$273	﹤0.01%	2891
2024 Q2	$36.9K	Buy	+6,355	New	+$36.9K	﹤0.01%	2941